If you need more lookups,
subscriptions start at $34 USD/month.
Thomas Schirrmann Location
Brunswick, NDS, DE
Thomas Schirrmann Work
CEO @ (January 2013 - Present)
Chief Operating Officer @ (September 2020 - January 2026)
CEO @ Corat Therapeutics GmbH (May 2020 - September 2020)
Research Group Leader @ (January 2005 - December 2013)
Promotion @ (January 2001 - December 2004)
Scientist @ (January 1997 - December 2001)
Thomas Schirrmann Education
Humboldt-Universität zu Berlin
PhD, Dr. rer. nat. (Immunologie)
2001-2004
Humboldt-Universität zu Berlin
Diplom (Biochemie)
Thomas Schirrmann Skills
Phage Display
Monoclonal human Antibodies
Bispecific antibodies
Therapeutic antibody fusion proteins
Antibody engineering
Affinity maturation
Immunology
Tumor Immunology
Molecular Biology
Protein Engineering
Protein Assays
Protein Expression
Mammalian Cell Culture
Bacterial Culture
Protein Production
Social Media
Therapeutic Antibody
Strategy
Microsoft Excel
Monoclonal Human
Project Management
Customer Service
Biotechnology
Marketing
Thomas Schirrmann Summary
Thomas Schirrmann, based in Brunswick, NDS, DE, is currently a CEO at YUMAB GmbH. Thomas Schirrmann brings experience from previous roles at Corat Therapeutics, Corat Therapeutics GmbH, TU Braunschweig and Charité. Thomas Schirrmann holds a 2001 - 2004 PhD, Dr. rer. nat. in Immunologie @ Humboldt-Universität zu Berlin. With a robust skill set that includes Phage Display, Monoclonal human Antibodies, Bispecific antibodies, Therapeutic antibody fusion proteins, Antibody engineering and more. Thomas Schirrmann has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Thomas Schirrmann?
Find contact details for 700 million professionals.